DUBLIN, June 27, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Global High-density Multiplexed Diagnostic Assays Market 2017-2021" report to their offering.
The global high density multiplexed diagnostic assays market to grow at a CAGR of 15.01% during the period 2017-2021.
The report, Global High density multiplexed diagnostic assays Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
One trend in the market is introduction of automated multiplexed PCR assays. There are automated multiplex systems for simultaneously screening hepatitis B virus, hepatitis C virus, and HIV-1 in blood donations. This helps in reduced hands-on time and elimination of errors with high sensitivity and specificity.
According to the report, one driver in the market is increasing equipment rental agreements. Most of the instruments such as clinical chemistry analyzers, immunochemistry analyzers, and multiplexed diagnostic equipment used in the IVD market are provided for rental or lease to the end-users. They need to pay for the initial installations and consumables. Leasing the high-cost instruments is an effective and convenient purchasing alternative for the end-users with limited budgets.
Further, the report states that one challenge in the market is high cost of multiplexed diagnostic assay equipment. The rise in prevalence of infectious diseases such HIV/acquired immunodeficiency syndrome (AIDS) and Hepatitis B has led to the increased use of high-density multiplexed diagnostic assays for screening of infectious agents. It helps in shortening the turn-around time, as it is highly sensitive. For example, in the case of detection of HIV, NAT screening reduces the turn-around time from 20 days to six days. It also helps in the detection of the low level of viral DNA or RNA present in the blood.
- Thermo Fisher Scientific
- F. Hoffmann-La Roche
Other prominent vendors
- Agilent Technologies
- Bio-Rad Laboratories
- Erba Diagnostics
- GOLD STANDARD DIAGNOSTICS
- Randox Laboratories
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by product
PART 07: Market segmentation by end-user
PART 08: Geographical segmentation
PART 09: Decision framework
PART 10: Drivers and challenges
PART 11: Market trends
PART 12: Vendor landscape
PART 13: Key vendor analysis
For more information about this report visit https://www.researchandmarkets.com/research/5z7x65/global
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets